CONFERENCE UPDATE: ILC 2022

HCC incidence reduced with HBsAg seroclearance VS. Viral suppression in cirrhotic CHB patients

GASTROENTEROLOGY & HEPATOLOGY
10 Nov 2022

Glossary: AFP: Alpha-fetoprotein; aHR: Adjusted hazard ratio; ALT: Alanine aminotransferase; cccDNA: Close covalent circular deoxyribonucleic acid; CHB: Chronic hepatitis B; cHR: Crude hazard ratio; CI: Confidence interval; FIB-4: Fibrosis-4 index; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; HCC: Hemtocellular carcinoma; NA: Nucleos(t)ide analogue; PS: Propensity score

Get access to our exclusive articles.
Related Articles

TAF for pregnant Chinese women with active CHB

Glossary: AE: Adverse event; ALT: Alanine aminotransferase; CHB: Chronic hepatitis B; HBeAg: Hepatitis B e-antigen; HBsAg: Hepatitis B surface antigen; HBV: Heaptitis B virus; DNA: Deoxyribonucleic acid; QD: Once a day; TAF: Tenofovir alafenamide; TDF: Tenofovir disoproxil fumarate; WHO: World Hea
GASTROENTEROLOGY & HEPATOLOGY OBSTETRICS & GYNECOLOGY
08 Nov 2022

Evaluation of the clinical and economic values of SOF/VEL in CHC patients
GASTROENTEROLOGY & HEPATOLOGY
08 Nov 2022

The pharmacokinetics, safety, and antiviral efficacy of taf in children and adolescent with CHB

Glossary: AASLD: American Association for the Study of Liver Diseases; ALT: Alanine aminotransferase; BMD: Bone mineral density; CHB: Chronic hepatitis B; CLCr: Creatinine clearance; HBeAg: Hepatitis B e-antigen; HBV: Hepatitis B virus; DNA: Deoxyribonucleic acid; PBO: Placebo; QD: Once a day; sCr
GASTROENTEROLOGY & HEPATOLOGY PEDIATRICS
08 Nov 2022

The efficacy and safety of TAF vs. TDF in treatment-naïve CHB patients

Glossary: AASLD: American Associatioin fo the Study of Liver Diseases; ALT: Alanine aminotransferase; CHB: Chronic hepatitis B; DNA: Deoxyribonucleic acid; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; PS: Propensity score; sCr:
GASTROENTEROLOGY & HEPATOLOGY
08 Nov 2022

HCC incidence after HCV cure among patients with advanced fibrosis of cirrhosis

Glossary: aRR: Adjusted rate ratio; CI: Confidence interval; HCC: Hematocellular carcinoma; HCV: Hepatitis C virus

GASTROENTEROLOGY & HEPATOLOGY ONCOLOGY
08 Nov 2022

Switch to TAF for improved efficacy and bone density in CHB patients

Glossary: ALT: Alanine aminotransferase; aOR: Adjusted odd ratio; BMD: Bone mineral density; CHB: Chronic hepatitis B; CI: Confidence interval; CKD: Chronic kidney disease; CR: Complete response; DNA: Deoxyribonucleic acid; eGFR: Estimated glomerular filtration rate; ETV: Entecavir; HBV: Hepatitis
GASTROENTEROLOGY & HEPATOLOGY
08 Nov 2022

The risk of HCC in CHB patients receiving TDF- or ETV-based regimens

Glossary: aHR: Adjusted hazard ratio; CHB: Chronic hepatitis B; CI: Confidence interval; ETV: Entecavir; HBeAg: Hepatitis B e-antigen; HCC: Hematocellular carcinoma; HR: Hazard ratio; IPD: Individual patient data; TDF: Tenofovir disoproxil fumarate

GASTROENTEROLOGY & HEPATOLOGY
07 Nov 2022

Switching to TAF shows high long-term efficacy and safety among CHB patients in real-world setting

In a multicenter, retrospective cohort study, switching from other nucleos(t)ide analogues (NAs) to tenofovir alafenamide (TAF) was found to be effective in improving outcomes among patients with chronic hepatitis B (CHB) and safe for up to 3 years.1 This study added substantially to the evidence of efficacy and safety of TAF in the real-world setting, supporting its wider adoption in light of the rapidly aging CHB population and increasing the prevalence of aging-related comorbidities.1
31 Oct 2022

Scenario 3: Preservation of renal function with early use of TAF in CHB patients with prevailing eGFR

Preservation of patients' renal function can be crucial in the management of CHB. Some patients such as those with cardiovascular diseases, despite having a prevailing eGFR. are more likely to have their renal function declined in the long term. Also. cancer patients frequently encounter infections that may lead to kIdney injury through sepsis or use come nephrotoxic antibiotics, such as aminoglycoside. Tenotovir alafenamide (TAF). a novel option with the benefits of preserving patients . is a major advance in the treatment landscape of CHB in recent years and can be the preferred therapy for CHB patients for the renal benefits.
08 Aug 2022